In particular, we genetically engineered murine oral squamous cell carcinoma (OSCC) cell lines to express the vesicular membrane-associated protein CD63, fused with enhanced green fluorescence protein (CD63-eGFP) under the control of a CSC-specific promoter. This evidence concerns the gene CD63 and oral cavity squamous cell carcinoma.